Literature DB >> 6472541

An abnormality of the fourth component of complement associated with benign recurrent hematuria.

T R Welch, A E Stitzel, R E Spitzer.   

Abstract

A group of 9 children with persistent isolated hematuria in the absence of other evidence of renal disease is presented. The children represent about one third of our patients with benign recurrent hematuria and are unique in that their C4s, in a functional assay, are lower than one would expect from their immunochemical level, resulting in an abnormally low C4 hemolytic efficiency. This feature occurs in the absence of any other evidence of complement dysfunction. Similar abnormalities were not seen in patients with other hypocomplementemic renal disease or congenital C4 deficiency. The patients' C4 molecules were identical to normal in charge, mobility, antigenic configuration, and ability to participate in an immune reaction. All patients had at least one C4 null gene on genetic analysis and 3 had double null genes. A similar pattern of C4 abnormality was not found in other patients with hypocomplementemic renal disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472541     DOI: 10.1159/000183295

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Difference in the biological properties of the two forms of the fourth component of human complement (C4).

Authors:  J A Schifferli; G Steiger; J P Paccaud; A G Sjöholm; G Hauptmann
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

2.  C4 uremic variant: an acquired C4 allotype.

Authors:  T R Welch; L Beischel
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Hereditary partial deficiency of the third component of complement associated with minimal change nephrotic syndrome.

Authors:  J E Springate; R H McLean; J A Winkelstein; L G Feld
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

4.  C7 deficiency and persistent haematuria.

Authors:  T Sakano; T Hamasaki; M Mori; T Ohta; K Ueda; K Ishigame; M Kawamura; N Takeda
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.